Back
Invesco Biotechnology & Genome ETF (PBE) Price
PBE Stock Price Chart
PBE Stock Price Prediction
Invesco Biotechnology & Genome ETF
$80.91
-1.26%
$-1.03
At close: Jan 16, 16:00:00 GMT-5
$80.26
-0.79%
$-0.64
Pre-market: Jan 20, 09:25:25 GMT-5
PBE Stock Price Prediction Summary
PBE stock price ended at $80.91 on Friday, after dropping 1.27%
On the latest trading day Jan 16, 2026, the stock price of PBE fell by 1.27%, dropping from $82.15 to $80.91. During the session, the stock saw a volatility of 1.53%, with prices oscillating between a daily low of $80.91 and a high of $82.15. On the latest trading day, the trading volume for PBE rose by 8.9K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 13.9K shares were traded, with a market value of approximately $256.5M.
PBE Technical Signals
Technical Signals Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
PBE currently exhibits 4 buy signals and 2 sell signals. The stock has been in an downtrend since 12:00 AM, with a total price change of -1.52% during this period. Overall, the technical indicators point to a Buy outlook for the mid-term.
Bullish/Bearish Signals for PBE
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for PBE. These insights help you make informed investment decisions.
Key Stats
Prev.Close
$81.94
Open
$81.36
Day's Range
$80.26 - $82.15
52 week range
$54.52 - $84.18
Volume
13.8K
Avg.Volume
5.8K
EPS (TTM)
--
Dividend yield
--
Market Cap
$254.5M
What is PBE?
PBE was created on 2005-06-23 by Invesco. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 261.65m in AUM and 32 holdings. PBE tracks a tiered equal-weighted index of companies principally engaged in biotechnology and genetic engineering.
Features
Trading Strategies
Resources
© 2025 Finture Development Limited. All rights reserved